Metastasis to the heart is compared with that to other target sites in terms of incidence, tissue susceptibility, and cancer cell injury within the microcirculation. At necropsy the myocardium is the sixth most common tion, in each type of primary cancer not only must a distinction be made between the incidence in patients with metastatic and nonmetastatic disease but also attention must be given to the occurrence of metastatic "cascades", as discussed later.
The aims of this paper are first to record and comment on the incidence of cardiac metastasis seen at necropsy in cases with a history of different, metastasing "solid" cancers. Second, this incidence will be compared with that of other target organs. Third, the susceptibility of the myocardium to haematogenous metastasis will be compared with that of other organs by use of metastatic efficiency indices.
Finally, some mechanisms influencing the development of haematogenous metastasis in the myocardium will be discussed in the light of In addition, only in the case of colorectal carcinoma does the incidence of cardiac metastasis lie between the values for the skin and thyroid, which have blood flows respectively above and below that in the myocardium. Therefore, although the delivery of cancer cells to target organs is an absolute requirement for metastasis, it does not account for the incidence patterns recorded here. However, the only data available on incidence relate only to whether or not evidence of metastasis was detected in any site, not how many metastases were present.
The disparity between cancer cell delivery and blood flow is addressed by the "seed-andsoil" hypothesis of Paget.'8 In this, differential interactions between different sites ("soils") and different types of cancer cells ("seeds") are thought to determine the relative susceptibilities of target sites to metastasis.
To discriminate between the differential delivery of cancer cells and differential interactions with target sites after delivery a semiquantitative metastatic efficiency index (MEI) (percentage incidence of organ involvement divided by organ blood flow (ml/min) was developed.5 In the initial study of the involvement of eight different target sites by metastasis from 19 groups of primary cancers, the MEIs that could be calculated in 135 of 152 possible situations, fell into three decades. Most (65%) had values of 0-01-0-09, 20% had values of 0 1-0-9 (indicating a "friendly" microenvironment with a relatively high incidence of metastasis per unit number of delivered cancer cells), and in contrast 15% had MEIs of 0-0 009 (indicating a "hostile" environment with a relatively low incidence of metastasis per delivered unit). Table 2 shows the MEIs calculated for 76 of 80 possible combinations of primary and target sites: 48 (63%) fell into the middle decade, which included all cases of cardiac metastasis. The mean (SEM) MEI for these lesions was 0 039 (0 006), including metastasis from primary cancers of the cervix uteri (0025), bladder (0-049), and uterus (0.070). Therefore, although the incidence of myocardial metastasis was sixth in the hierarchy of the eight target sites reported, on the basis of MEI only 16 (20%) of 76 of other sites fell into the higher susceptibility decade and, of these, most were in the adrenals and thyroid.
Death of cancer cells in the myocardial microcirculation Among those patients dying with metastatic cancer in the present study, between 83 and 98% did not have cardiac metastases detectable at necropsy. Large numbers of cancer cells must have been delivered to the myocardium but most of them must have failed to grow into metastases. This is an example of metastatic inefficiency. 8 Interactions of cancer cells with the microvasculature of target sites are thought to be important rate regulators of haematogenous metastasis.'9 Studies in laboratory animals20 showed that most cancer cells delivered to the myocardium via the coronary arteries after left ventricular injection are killed within several minutes: virtually no cancer cells were detected on histochemical examinations, and sensitive myocardial bioassays indicated that between 80% and 95% of cells entering the myocardium were rapidly killed. Cancer cell death was not due to the toxicity of the myocardium per se. Fewer cancer cells were killed when they were added to minced myocardium, which indicates that toxicity of the myocardium alone did not explain cancer cell killing.
One mechanism accounting for the destruction of cancer cells in the microvasculature of the heart and other target organs comes from considerations of cell geometry.62' In vessels down to arteriolar diameter, circulating cancer cells tend to remain spherical. But when they enter vessels that have smaller diameters than they do they become cylindrical. Because a sphere has the smallest surface area of any body of equal volume, this transformation from sphere to cylinder must be associated with an increase in the surface area of the cancer cells. This increase can be apparent and be accomplished by non-lethal surface unfolding or, if unfolding is insufficient to meet the geometric demands, the increase may be real and accomplished by stretching of the surface membranes of the cancer cells. Biological membranes in general cannot be stretched to increase their surface areas by more than 4%, before the tension within them rises to the critical level for rupture, with consequent cell death. Intravascular cancer cell deformation with increases in surface area and death has been directly demonstrated by vital microscopy and has been shown to be the result of mechanically induced deformation. 
